Opioid guidelines in the management of chronic non-cancer pain.
about
Estimating the prevalence of opioid diversion by "doctor shoppers" in the United StatesPrimary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settingsKey Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics.Evidence and consensus recommendations for the pharmacological management of pain in India.Prevalence of opioid dispensings and concurrent gastrointestinal medications in QuebecOpioids for chronic noncancer pain: a new Canadian practice guidelinePreparation, confidence, and attitudes about chronic noncancer pain in graduate medical educationDifferential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses.Extended-release morphine sulfate in treatment of severe acute and chronic painIdentifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM)The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.Opioids and the treatment of chronic pain: controversies, current status, and future directions.Representations of OxyContin in North American newspapers and medical journalsLong-term chronic opioid therapy discontinuation rates from the TROUP studyPredictors of change in pain and physical functioning among post-menopausal women with recurrent pain conditions in the women's health initiative observational cohortSubstance use disorders in a primary care sample receiving daily opioid therapy.Survey of select practice behaviors by primary care physicians on the use of opioids for chronic painEfficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain.The narcotic bowel syndrome: clinical features, pathophysiology, and managementDifferences in poisoning mortality in the United States, 2003-2007: epidemiology of poisoning deaths classified as unintentional, suicide or homicide.Polydrug abuse: a review of opioid and benzodiazepine combination useOpioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review.A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework.Profile of female patients seeking in-patient treatment for prescription opioid abuse from a tertiary care drug dependence treatment centre from India.Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.Opioid rotation in patients initiated on oxycodone or morphine: a register study.Prescription opioid abuse: challenges and opportunities for payers.Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study.Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphineCan abuse deterrent formulations make a difference? Expectation and speculation.Issues in long-term opioid therapy: unmet needs, risks, and solutions.A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needsPersistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.Sex Differences in Microglia Activity within the Periaqueductal Gray of the Rat: A Potential Mechanism Driving the Dimorphic Effects of Morphine.The analgesic activities of Stauntonia brachyanthera and YM11 through regulating inflammatory mediators and directly controlling the sodium channel prompt.Neurophysiology of pain and hypnosis for chronic pain.Interdisciplinary team-based care for patients with chronic pain on long-term opioid treatment in primary care (PPACT) - Protocol for a pragmatic cluster randomized trial.
P2860
Q28534694-DE3CD417-C80E-4264-824F-581C541FE74AQ30739017-3867EA65-8252-49B3-ABA7-54EC9FC6856FQ30760780-3D4937E8-60FD-4BE2-AC95-CAD424507EB0Q30844805-437F9BCB-209A-48D7-869D-F86E994811AEQ33562118-134ACF39-AE81-44CD-9E61-A44B71E4948AQ33900792-C55BF241-EBD4-484A-AEB2-11CBCC0089E8Q34092540-DB164842-5B86-49DE-9DF8-4BA4D4FC60EFQ34154381-7AC0FD9D-98FF-4B79-A06C-FA38EE4C5058Q34418327-CE4AC6D1-058D-4FAE-A8E5-731028A22DD6Q34521652-AE2DB1D4-DFCB-4086-82E7-E7B3DA5129C4Q34661770-61F9D88E-69D2-4905-BE73-C89FE7AFB0B2Q34751280-B331184D-EA27-480B-B4F6-08E7A216D37FQ34846394-AFC09BD5-3CDA-485E-8B80-7C77D3B09981Q35453224-37805919-A019-4300-9113-2A7D74D173F5Q35606850-6E5EBEE8-9B91-49C0-A4BB-8C5940A6C74CQ35645826-9B475FC3-64EC-4CAF-8FDF-0DDA44FEECA4Q35962711-A3E9B8E8-2157-428B-8E07-F736CC70C8D2Q35962717-0E6BF222-A492-480D-BDB4-11FFA930FA4EQ36078321-DA773747-2B8C-405F-AB7A-E42FEFA2948AQ36136622-FC881075-C040-4940-856F-B10D6EA94F7BQ36153818-9F7146F6-4D31-4A8E-B01A-B3786D123BCDQ36266246-57E3EE69-C69A-4512-A0DF-8A51B6DE7E12Q36542707-EB0BACA9-1E63-4A0E-8006-BB6223A72109Q36626553-166D75C5-59E9-4338-8475-B45396B7E4D0Q36769727-D0C6E63D-3E0D-437B-9A08-367FD4714211Q36794523-613F6879-6097-4AA6-8B12-62234C2B9126Q36870860-22F8429F-4342-4BCC-86C2-E9CF52A4945AQ36922546-39402DB0-355D-47E6-8705-269CC49B3D45Q37141254-6F5F1F92-E522-4CE3-9017-81F18E03467BQ37208498-F40907DD-11C4-4E48-8FC5-59D2FEFD4966Q37223480-A232C0AF-C658-4B70-97DF-14336A615002Q37246241-E920623D-EF61-4614-AE84-2304448D79E2Q37246245-AA343099-31BA-4AC4-9381-563843D6CA63Q37710121-7B3C5D3E-18B5-426E-A4E3-DD19E563DAE3Q38951157-49BEE656-F9CE-4BF3-9576-89B9FBE7C69EQ41311699-94B00AE3-F28C-40D1-859E-887A2DE907FBQ43083206-F74E9FF3-A887-4543-BE15-5A69B6A9D21CQ51742132-6420E90D-1B01-4434-A4C2-858EF5EBDF6B
P2860
Opioid guidelines in the management of chronic non-cancer pain.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Opioid guidelines in the management of chronic non-cancer pain.
@ast
Opioid guidelines in the management of chronic non-cancer pain.
@en
type
label
Opioid guidelines in the management of chronic non-cancer pain.
@ast
Opioid guidelines in the management of chronic non-cancer pain.
@en
prefLabel
Opioid guidelines in the management of chronic non-cancer pain.
@ast
Opioid guidelines in the management of chronic non-cancer pain.
@en
P2093
P921
P1476
Opioid guidelines in the management of chronic non-cancer pain
@en
P2093
Aaron K Calodney
Andrea M Trescot
Arthur E Jordan
Benjamin W Johnson
Bentley A Ogoke
Elmer E Dunbar
Hans C Hansen
John R Swicegood
Joseph F Jasper
Kenneth G Varley
P577
2006-01-01T00:00:00Z